Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | +3.79% | -1.48% | -28.85% |
05-13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
05-08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.85% | 195M | |
+16.41% | 79.16B | |
+8.35% | 8.72B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Zevra Therapeutics Names Neil McFarlane Chief Executive